A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH)
Study context
- Population
- Individuals with echocardiographic concentric left ventricular hypertrophy (LVH), not treated for hypertension and without known cardiomyopathyapproximately
- Participants
- 600 individuals
- Planned comparison
- Centralized notification and clinical support pathway vs no intervention
- Primary endpoint
- Initiation of an antihypertensive medication
- Follow-up
- 12 months from start
Methodological detailsprotocol/design paper, pragmatic, large integrated healthcare system, Trial began in March 2023
- Protocol/design paper
- Pragmatic
- Large integrated healthcare system
- Trial began in March 2023
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH). Am Heart J. Published 14 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →